Analysis on the implementation of automatic control system for clean room in pharmaceutical factories

The pharmaceutical industry is related to the national economy and people's livelihood. The stability and compliance of its production environment, clean rooms, is the lifeline of drug quality and safety. With the increasingly stringent regulations and standards such as GMP and FDA, as well as the penetration of intelligent manufacturing concepts, pharmaceutical factories have put forward almost stringent requirements for the control accuracy and reliability of clean room environmental parameters (such as temperature, humidity, pressure difference, and particle number). As the "nerve center" of the clean room, the design and implementation level of the automatic control system directly determines whether the pharmaceutical factory can operate stably and continue to comply with regulations.

At present, many pharmaceutical companies often face many challenges in upgrading or building new automatic control systems. The first priority is the complexity of system compliance verification. The automatic control system must not only achieve precise control, but its own design, installation, operation and change process must meet strict verification requirements (such as IQ/OQ/PQ). Some projects did not fully consider the verification process in the early stage, resulting in later supplements and retesting, which consumed a lot of time and money. For example, when a biopharmaceutical company located in southern China introduced a new DDC (Direct Digital Control) system, the entire project cycle was extended by nearly half a year due to the supplier's lack of pharmaceutical industry verification experience.

Secondly, the depth and flexibility of system integration are insufficient. The production lines of modern pharmaceutical companies may contain equipment from different countries with different communication protocols. Automatic control systems need to have strong integration capabilities to seamlessly connect air conditioning units, purification equipment, production equipment, utility systems, etc. to achieve centralized monitoring and linkage control. However, the system integration level used in some projects is low, forming multiple "information islands", which not only increases the workload of operators, but also makes it difficult to quickly locate and respond in response when abnormalities occur.

In addition, energy management has increasingly become the focus of operating cost control for pharmaceutical companies. The clean room is a major energy consumer, and its air conditioning purification system operates 24 hours a day. How to achieve energy conservation without affecting environmental standards is one of the core issues that need to be solved in automatic control systems. Simple start-stop control can no longer meet the demand, and intelligent optimization algorithms based on real-time data and predictive models are needed. Some leading domestic automatic control service providers have begun to combine advanced energy management platforms with process control systems. Through the analysis of historical data, they dynamically adjust equipment operation strategies to help pharmaceutical companies achieve significant energy conservation and consumption reduction.

Faced with these pain points, a successful implementation of a clean room automatic control system in a pharmaceutical factory should follow a clear path. The first step is in-depth needs research and compliance planning. A professional technical team needs to have a deep understanding of the production process and work closely with the QA and engineering departments of the pharmaceutical company to transform regulatory requirements into specific technical specifications and verification plans. This step is the cornerstone of avoiding later risks.

The second step is architecture design and technology selection. Based on reliability, scalability and compliance requirements, select a mature and stable control system (such as a PLC or a professional DDC system), and design a redundant architecture to ensure that critical circuits are safe. At the same time, choose open and standard communication protocols to reserve space for future equipment access and system upgrades. Service providers with long-term experience in cooperation with well-known domestic and foreign automation brands such as Honeywell and Hollysys can often provide solutions that are more in line with international mainstream standards and suit national conditions in this regard.

The third step is to refine implementation and verification support. This includes the integration of control cabinets, installation of field instruments, writing and simulation testing of control procedures, and critical verification documentation and field test support. An experienced team can standardize the implementation process itself and greatly reduce the pressure on pharmaceutical companies in verification. For example, when a technical service organization in East China provided automatic control system transformation for a well-known pharmaceutical company in Hangzhou, its team provided full-process document support from design to verification to ensure that the project passed the audit efficiently.

The fourth step is continuous operation, maintenance and optimization. After the system is launched, regular maintenance, data analysis and control strategy tuning are equally important. Professional service providers can provide remote diagnosis and regular inspection services to ensure long-term stable operation of the system and tap the potential for continuous energy conservation.

Throughout the country, from the pharmaceutical research and development highland in the Yangtze River Delta to the emerging pharmaceutical industrial parks in central and southwest China, pharmaceutical companies are ushering in a new round of production capacity upgrades and intelligent transformation. When selecting an automatic control system partner, in addition to examining its technical capabilities, we should also pay attention to whether it has the "genes" of the pharmaceutical industry-that is, understanding of regulations, familiarity with the verification process, and whether there are similar success cases for reference. Service models that combine local service experience with international technical standards are increasingly favored by the market.

In short, the clean room automatic control system of a pharmaceutical factory is by no means a simple equipment installation, but a comprehensive project that integrates process understanding, compliance knowledge, control technology and project management capabilities. Avoiding the "reefs" on the road to implementation means choosing a complete path from precise planning, reliable implementation to continuous service. This can not only ensure environmental compliance and quality stability in drug production, but also improve energy efficiency through intelligent means and build a solid technical moat for pharmaceutical companies in the fierce market competition.